Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Bayer Beefs Up Biologics Pipeline With Direvo Biotech Buy

This article was originally published in The Pink Sheet Daily

Executive Summary

Separate spin-out transaction establishes Direvo’s industrial biotech business as an independent entity.
Advertisement

Related Content

Direvo CEO Thomas von Ruden: An Interview With “The Pink Sheet” DAILY
Direvo CEO Thomas von Ruden: An Interview With “The Pink Sheet” DAILY
Bayer Builds On Oncology Pipeline With Nycomed’s Divested Kinase Inhibitors
Bayer Schering Pharma SVP-Global Business Development And Licensing Michael Yeomans: An Interview With “The Pink Sheet” DAILY (Part 2 of 2)
Evotec/Oxford Asymmetry To Exchange Technology For Equity Investments
Evotec/Oxford Asymmetry To Exchange Technology For Equity Investments

Topics

Advertisement
UsernamePublicRestriction

Register

PS068348

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel